BioCurex, Inc.(fka BOCX)

[mcd2inga]

IMO, Abbott is doing nothing with Recaf.
The discussions may have gone something like this:
Abbott decided to return the license. Dr. Moro didn't want that and convinced them that Recaf would eventually be a commercial product. They modified the license to remove Abbott's responsibilities to develop further and let Abbott keep the $50,000. Biocurex will continue working with Recaf. If there is eventually a commercial product, then Abbott has the option to sell the product. Biocurex also has the option to cancel Abbott's license.
Basically, Abbott can just do nothing until someone else develops Recaf to a commercial product.

- I hope this isn't a duplicate. I wrote it once and lost it somehow.

mcd